Indeed, RANKL expression was reduced both in RA patient and healthy donor-derived NK cells following GSK-J4 treatment, as determined by RT-PCR and flow cytometry (Fig. 5, B and C). The gene discussed is TNFSF11; the disease is rheumatoid arthritis.